Status:
COMPLETED
Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis
Lead Sponsor:
Promius Pharma, LLC
Conditions:
Atopic Dermatitis
Eligibility:
All Genders
3-12 years
Phase:
PHASE4
Brief Summary
This study compares the effectiveness of two topical creams for atopic dermatitis in pediatric subjects. Subjects will be randomly assigned to use one of the two creams twice daily for 6 weeks or unti...
Eligibility Criteria
Inclusion
- at least 3 months of age and less than 13 years of age
- atopic dermatitis of moderate severity
Exclusion
- pregnant or lactating
- treatment of atopic dermatitis with topical product in the 14 days prior to Baseline
- treatment of atopic dermatitis with systemic product in the 30 days prior to Baseline
- serious or uncontrolled medical condition
- active infection
- significant use of inhaled, intranasal, or intraocular corticosteroid
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00828412
Start Date
March 1 2009
End Date
August 1 2009
Last Update
January 30 2017
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
National Jewish Health
Denver, Colorado, United States, 80206
2
Northwestern University
Chicago, Illinois, United States, 60611
3
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States, 27157
4
Dermatology Research Associates
Cincinnati, Ohio, United States, 45230